Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place

Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study included 52 patients with coronary heart disease and syst...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: L. I. Olbinskaya, Yu. I. Naymann
Format: Artigo
Langue:Russo
Publié: «SILICEA-POLIGRAF» LLC 2007-02-01
Collection:Кардиоваскулярная терапия и профилактика
Sujets:
chronic heart failure
pulmonary hypertension
endothelin
nebivolol
Accès en ligne:https://cardiovascular.elpub.ru/jour/article/view/1145
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires